Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glioblastoma and Other Primary Brain Malignancies in Adults
Lauren Schaff, Ingo K. Mellinghoff
JAMA (2023) Vol. 329, Iss. 7, pp. 574-574
Closed Access | Times Cited: 497

Showing 1-25 of 497 citing articles:

Glioblastoma Therapy: Past, Present and Future
Elena Obrador, Paz Moreno-Murciano, María Oriol‐Caballo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2529-2529
Open Access | Times Cited: 61
Histone H3K9 Lactylation Confers Temozolomide Resistance in Glioblastoma via LUC7L2‐Mediated MLH1 Intron Retention
Yue Qu, Zhao Wang, Yixiong Shen, et al.
Advanced Science (2024) Vol. 11, Iss. 19
Open Access | Times Cited: 31
Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers
Zhong Lan, Xin Li, Xiao-Qin Zhang
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 3040-3040
Open Access | Times Cited: 30
Glioblastoma and brain connectivity: the need for a paradigm shift
Alessandro Salvalaggio, Lorenzo Pini, Alessandra Bertoldo, et al.
The Lancet Neurology (2024) Vol. 23, Iss. 7, pp. 740-748
Closed Access | Times Cited: 16
BrainNet: Precision Brain Tumor Classification with Optimized EfficientNet Architecture
Md. Manowarul Islam, Md. Alamin Talukder, Md Ashraf Uddin, et al.
International Journal of Intelligent Systems (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 15
Recent Advances in Nanoenzymes Based Therapies for Glioblastoma: Overcoming Barriers and Enhancing Targeted Treatment
Liyin Wang, Min Gu, Xiaoli Zhang, et al.
Advanced Science (2025)
Open Access | Times Cited: 3
Glioblastoma: Clinical Presentation, Multidisciplinary Management, and Long-Term Outcomes
Dávid Sipos, Bence L. Raposa, Omar Freihat, et al.
Cancers (2025) Vol. 17, Iss. 1, pp. 146-146
Open Access | Times Cited: 2
Optimizing Therapeutics for Intratumoral Cancer Treatments: Antiproliferative Vanadium Complexes in Glioblastoma
Angie Bates, Kameron L. Klugh, Anna O. Galaeva, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 994-994
Open Access | Times Cited: 2
Role of the AKT signaling pathway in regulating tumor-associated macrophage polarization and in the tumor microenvironment: A review
Cong Liang, Song Wang, Chengwei Wu, et al.
Medicine (2025) Vol. 104, Iss. 5, pp. e41379-e41379
Open Access | Times Cited: 2
Mitochondria Transfer from Mesenchymal Stem Cells Confers Chemoresistance to Glioblastoma Stem Cells through Metabolic Rewiring
Jean Nakhle, Khattar Khattar, Tülin Özkan, et al.
Cancer Research Communications (2023) Vol. 3, Iss. 6, pp. 1041-1056
Open Access | Times Cited: 31
Targeting SIRT3 sensitizes glioblastoma to ferroptosis by promoting mitophagy and inhibiting SLC7A11
Xiaohe Li, Wenlong Zhang, Zhengcao Xing, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 14
Samarium doped carbon dots for near-infrared photo-therapy
Huixian Shi, Yanfei Yin, Hao Xu, et al.
Chemical Engineering Journal (2024) Vol. 488, pp. 150661-150661
Closed Access | Times Cited: 14
A Manganese‐Based Nanodriver Coordinates Tumor Prevention and Suppression through STING Activation in Glioblastoma
Wenyuan Zhang, Liejing Lu, Zheng Zhu, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 19
Closed Access | Times Cited: 13
Extensive Shrinkage and Long-term Stable Disease in a Teenage Female Patient With High-grade Glioma Treated With Temozolomide and Radiation in Combination With Oral Recombinant Methioninase and a Low-methionine Diet
MOTOKAZU SATO, Qinghong Han, KOHEI MIZUTA, et al.
In Vivo (2024) Vol. 38, Iss. 3, pp. 1459-1464
Open Access | Times Cited: 13
Stimulation of tumoricidal immunity via bacteriotherapy inhibits glioblastoma relapse
Yulin Zhang, Kaiyan Xi, Zhipeng Fu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Real-time glioblastoma tumor microenvironment assessment by SpiderMass for improved patient management
Yanis Zirem, Léa Ledoux, Lucas Roussel, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 4, pp. 101482-101482
Open Access | Times Cited: 12
Framework nucleic acid-based nanoparticles enhance temozolomide sensitivity in glioblastoma
Yufei Lan, Xiaodie Li, Boyang Liu, et al.
Drug Resistance Updates (2024) Vol. 76, pp. 101122-101122
Open Access | Times Cited: 12
Nanoparticles for efficient drug delivery and drug resistance in glioma: New perspectives
Jiyuan Liu, Fan Yang, Jinqu Hu, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 5
Open Access | Times Cited: 11
Nanoparticles Coated with Brain Microvascular Endothelial Cell Membranes can Target and Cross the Blood–Brain Barrier to Deliver Drugs to Brain Tumors
Huajian Chen, Jingsen Ji, Li Zhang, et al.
Small (2024) Vol. 20, Iss. 29
Closed Access | Times Cited: 10
Advances in Anti-Cancer Drug Development: Metformin as Anti-Angiogenic Supplemental Treatment for Glioblastoma
Siddharth Shah, Hadeel M. Mansour, Tania M. Aguilar, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5694-5694
Open Access | Times Cited: 10
Mitocytosis Mediated by an Enzyme‐Activable Mitochondrion‐Disturbing Polymer‐Drug Conjugate Enhances Active Penetration in Glioblastoma Therapy
Yufan Xiang, Bing Wang, Wanchun Yang, et al.
Advanced Materials (2024) Vol. 36, Iss. 18
Closed Access | Times Cited: 9
Suppression of ITPKB degradation by Trim25 confers TMZ resistance in glioblastoma through ROS homeostasis
Yuanliang Yan, Shangjun Zhou, Xi Chen, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 9
Recent advances in targeted drug delivery for the treatment of glioblastoma
Meng Mao, Yingjie Wu, Qiang He
Nanoscale (2024) Vol. 16, Iss. 18, pp. 8689-8707
Closed Access | Times Cited: 9
Metabolic Roles of HIF1, c-Myc, and p53 in Glioma Cells
Cristina Trejo‐Solís, Rosa Angélica Castillo‐Rodríguez, Norma Serrano‐García, et al.
Metabolites (2024) Vol. 14, Iss. 5, pp. 249-249
Open Access | Times Cited: 9
Biological Activity of Natural and Synthetic Peptides as Anticancer Agents
Luana Vittoria Bauso, Valeria La Fauci, S. Munaò, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7264-7264
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top